| RS2137673691 |
KCNA1
|
Health Risk |
Likely pathogenic |
— |
| RS2137673957 |
KCNA1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2137673958 |
KCNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic kinesigenic dyskinesia, Episodic ataxia type 1 |
| RS2137673961 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS2137673966 |
KCNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS2137679109 |
DLAT
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E2 deficiency, Pyruvate dehydrogenase E2 deficiency |
| RS2137688022 |
SUCLA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137688148 |
SUCLA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137691313 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137691925 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137694642 |
SUCLA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137698036 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137700684 |
DNAH10
|
Health Risk |
Pathogenic |
Spermatogenic failure 56, Spermatogenic failure 56 |
| RS2137703007 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2137703473 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2137704696 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2137705201 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137706560 |
KMT2D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Kabuki syndrome |
| RS2137706790 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2137707267 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137707335 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137707354 |
CEP290
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2137708500 |
PKP2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2137710225 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome 5, Joubert syndrome 5 |
| RS2137710573 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137710783 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137710791 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137710954 |
DPF2
|
Health Risk |
Likely pathogenic |
— |
| RS2137711041 |
DPF2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 7, Coffin-Siris syndrome 7 |
| RS2137711145 |
DPF2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 7, Coffin-Siris syndrome 7 |
| RS2137711618 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2137711696 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2137712168 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2137713030 |
CEP290
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 6, Senior-Loken syndrome 6 |
| RS2137714332 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2137715091 |
KMT2D
|
Health Risk |
Pathogenic |
Vein of Galen aneurysmal malformation, Kabuki syndrome |
| RS2137715433 |
SUCLA2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137716138 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137717323 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137718161 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137718533 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137718900 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137719240 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137719772 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137720420 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS2137720760 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137720951 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2137721150 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137721367 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137722808 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS2137724246 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137725980 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137726985 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137729385 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137737853 |
OTOGL
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2137738321 |
OTOGL
|
Health Risk |
Pathogenic |
— |
| RS2137742889 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2137743400 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137743496 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS2137743517 |
SACS
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137748028 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137772673 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137773640 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS2137774389 |
PKP2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137777604 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS2137777670 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137778300 |
PKP2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137779120 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2137781223 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2137783366 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137805318 |
B3GLCT
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2137827783 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2137828445 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2137829787 |
PKP2
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2137830958 |
PKP2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, PKP2-related disorder |
| RS2137831087 |
PKP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137836218 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2137836547 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS2137837524 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137837678 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137842716 |
CDK8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia and behavioral abnormalities, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS2137852356 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137856827 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS2137862074 |
PFKM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VII |
| RS2137863489 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS2137866137 |
RNASEH2B
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS2137866261 |
RNASEH2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 2, RNASEH2B-related disorder |
| RS2137866660 |
RNASEH2B
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS2137868283 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137868361 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2137870396 |
ATP2A2
|
Health Risk |
Pathogenic |
ATP2A2-related disorder, ATP2A2-related disorder |
| RS2137874352 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2137874802 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137875677 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137876114 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS2137876491 |
OTOGL
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 84B, Autosomal recessive nonsyndromic hearing loss 84B |
| RS2137877191 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2137878257 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2137879945 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2137881468 |
B3GLCT
|
Health Risk |
Likely pathogenic |
— |